Could GLP-1 Receptor Agonists Reduce the Risk of Neurologic Disorders?
Dr. Tesha Monteith discusses the Brain & Life article, "Could GLP-1 Receptor Agonists Reduce the Risk of Neurologic Disorders?" by Hallie Levine, available in the latest issue of Brain & Life or at…
Read the full articleYou might also wanna read
GLP-1 receptor activation linked to lower depression and bipolar disorder odds
Genetic analyses linked BMI-related GLP-1 receptor activation to better mental well-being and lower odds of major depressive disorder and bi
Real-world study suggests GLP-1 receptor agonists may reduce emergency visits and medication needs for chronic migraine
Real-world data suggest GLP-1 receptor agonists may reduce emergency care visits and the need for additional migraine treatments in adults w
mdsc.pe·6d agoGLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation
Conditions : Alzheimer Disease; Diabetes Mellitus Type 2; Obesity & Overweight Interventions : Drug: GLP-1 Receptor Agonists; Drug: DPP-4 In
GLP-1 Therapy Reduces Migraine Frequency by More Than Half in Obesity Patients
A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half
medlink.com·7mo ago
GLP-1 Receptor Agonists Linked to Small Risk of Smell and Taste Disturbances in Type 2 Diabetes
The absolute risk appears low, but new data suggest small changes in smell and taste with GLP-1 treatment may exceed those already associate
mdsc.pe·15d ago
GLP-1 Drugs Linked to 30% Lower Breast Cancer Risk in New Study
New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the future.
forbes.com·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.